Goldman Sachs’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
299,045
+87,172
| +41% | +$477K | ﹤0.01% | 3541 |
|
|
2025
Q1 | $1.33M | Sell |
211,873
-24,271
| -10% | -$153K | ﹤0.01% | 3630 |
|
|
2024
Q4 | $973K | Buy |
236,144
+71,906
| +44% | +$296K | ﹤0.01% | 3937 |
|
|
2024
Q3 | $549K | Buy |
164,238
+91,045
| +124% | +$304K | ﹤0.01% | 4069 |
|
|
2024
Q2 | $218K | Buy |
73,193
+35,219
| +93% | +$105K | ﹤0.01% | 4329 |
|
|
2024
Q1 | $131K | Buy |
37,974
+14,059
| +59% | +$48.5K | ﹤0.01% | 4414 |
|
|
2023
Q4 | $32K | Sell |
23,915
-2,235
| -9% | -$3K | ﹤0.01% | 4586 |
|
|
2023
Q3 | $57K | Sell |
26,150
-8,901
| -25% | -$19.4K | ﹤0.01% | 4469 |
|
|
2023
Q2 | $83.8K | Buy |
+35,051
| New | +$83.8K | ﹤0.01% | 4594 |
|